The Preclinical Testing Strategy for the Development of Novel Chemical Entities for the Treatment of Asthma

E-ISSN： 1873-5592|9|6|443-451

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.6, 2008-06, pp. : 443-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutics for the treatment of asthma

By Chantry D.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 321-328

Informa Healthcare

Access to resources Recommend Favorite

Evolving Novel Chemical Entities for Management of Benign Prostatic Hyperplasia#

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 7, 2017-04 ,pp. : 593-602

Bentham Science Publishers

Access to resources Recommend Favorite

Novel bronchodilators in the treatment of asthma and COPD

By Campillo Nuria Páez Juan Antonio

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2001-01 ,pp. : 53-63

Informa Healthcare

Access to resources Recommend Favorite

Calix[n]arenes as Goldmines for the Development of Chemical Entities of Pharmaceutical Interest

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6507-6521

Bentham Science Publishers

Access to resources Recommend Favorite

The preclinical discovery and development of ezogabine for the treatment of epilepsy

By Jankovic Slobodan Ilickovic Ivana

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1429-1437

Informa Healthcare

Access to resources Recommend Favorite